EnChannel Medical is a high-tech medical device research and development company dedicated to developing next-generation technologies and products for the treatment of atrial fibrillation, providing cardiac electrophysiologists and patients with atrial fibrillation with simpler, safer and more efficient diagnosis, treatment and management. The company has three subsidiaries in Guangzhou, Shanghai Pudong China, and Orange County, USA, which undertake different R&D and manufacturing tasks of the company. The company is committed to the research and development, production and sales of medical equipment and interventional and implantable devices used in the diagnosis and treatment of atrial fibrillation. Its business scope includes medical device research and development, production, technical consultation, technical services, and sales. The company's current main technology and R&D and production products will be used in the following fields: 1. Catheter ablation of atrial fibrillation 2. Three-dimensional mapping of atrial fibrillation. 3. Atrial fibrillation monitoring and management The company's core technologies are pulsed electric field ablation (PFA) technology, cardiac three-dimensional navigation, and mapping technology, and intracardiac ultrasound technology. The company's R&D team is committed to applying core technologies to the diagnosis and treatment of atrial fibrillation, and we are providing excellent products and technical services for cardiac intervention and implantation for patients with atrial fibrillation. We are always committed to continuously seeking and providing solutions for cardiac pacing and electrophysiologists to improve control during treatment and reduce risk. The company's mission is to make arrhythmia intervention easier and safer. The company's long-term goal is to become the world's most outstanding company in the prevention, diagnosis, treatment and postoperative management of atrial fibrillation.